Bradenton, Feb 10, 2020 (Issuewire.com) - TheHummingMask, a newly invented device turned out to be helpful against the impact of the new coronavirus (2019-nCoV). The function is based on the effect of Nitric oxide, which can inhibit the development of lung infections such as pneumonia.
After 5 years of research and development, the US/Dutch based company just produced the first improved devices available for home use and professional use. The earlier devices were intended to prevent high blood pressure, asthma, and various other general health issues and geriatric illnesses.
The function and effect of inhibiting pneumonia are achieved by inhaling our own natural produced (Bio) Nitric oxide (NO) permanently available in our sinuses and nasal cavities. TheHummingMask© resonates with the air containing this NO, making it available to inhale by breathing in through the nose (iNO). Different detailed studies reveal how inhaled Nitric oxide(iNO) can help, as the inhaled NO is a potent virus killer. Also, bacteria and fungi are not resistant to this iNO. Bio-Nitric oxide is a natural and physically produced molecule. Instantly at first use theHummingMask© provides immediate relief in breathing by a.o. the release of mucus in the lungs and trachea.
That NO has the capability to inhibit the development of different pneumonia's e.g. caused by the Coronavirus(es) which is similar to the SARS is explained in many official published studies. (see below for studies and publications).
2: Inhalation of nitric oxide in the treatment of Severe Acute Respiratory Syndrome: A Rescue trail in Beijing.
Taking in to consideration that the Coronavirus is causing severe acute respiratory syndrome (SARS) pandemic of 2002-2003, and the Middle East respiratory syndrome (MERS) outbreak in South Korea in 2015 belongs to the same family* of viruses as the 2019-nCov novel Coronavirus, it is expected to have the same results as proved in the studies published January 2020.
*Quote: The full virus genome had about an 89% nucleotide identity with bat-SL-CoVZC45, which makes it a new species. Moreover, the Spike protein of our virus has an 84% nucleotide identity with the bat-SL-CoVZC45 coronavirus and a 78% nucleotide identity with the human SARS Coronavirus.
(Source: The Lancet. Published: January 24, 2020DOI)**
The above information makes the availability of theHummingMask© advisable, since at this moment there is no other close solution or treatment available to fight conventional pneumonia caused by viruses in general and in particular against pneumonia caused by the 2019-nCov novel Coronavirus. The only solution right now is that the body itself fights pneumonia even with a weak immune system or older age, along with medication against fever and pain release.
Production:
Production capacity is set at only 1.500 items per month but can be increased rapidly when demand rises. Product patent pending© 2020
For more information;
Please email thehummingmask@gmail.com or go to www.thehummingmask.org
**https://www.thelancet.com/action/showPdf?pii=S0140-6736%2820%2930154-9
Media Contact
Vital Health Inventions LLC
7143503924
United States - Florida
Source :Vital Health Inventions LLC
This article was originally published by IssueWire. Read the original article here.
